Clinical Trial Update: Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer [Phase 4]

View source ↗

Summary

Clinical trial update evaluating the TrueBeam radiotherapy system for low-to-intermediate risk prostate cancer in Phase 4. The document provides sponsor and pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Neoplasms

Drugs mentioned

• TrueBeam Radiotherapy System

Snippet

Sponsor: Albert DeNittis | Conditions: Prostate Neoplasms | Phase 4 | Status: UNKNOWN